TECH OFFERS

In a world where resources are diminishing and demands are rising, the value of land has significantly increased for clean energy and food production. Agrivoltaic farming represents a potential game-changing solution that can bring substantial benefits to both the energy and food sectors. The patented technology is a tubular solar photovoltaic (PV) module designed for agrivoltaic farming. The unique tubular nature of the system allows sunlight, water, and wind to reach the plants below while simultaneously harnessing solar power. Moreover, the tubular modules can provide consistent partial shading to protect the plants and reduce ambient temperature and ground moisture loss. This technology enables the dual use of land by integrating agricultural activities such as farming and gardening with solar power generation, maximising the value derived from the limited land. The combination of energy harvesting and agriculture has significant potential to improve farming productivity, increase land-use efficiency, reduce carbon emissions, and promote environmental sustainability. The technology owner is keen to collaborate with partners interested in agrivoltaic farming like farmers, gardeners, agritech companies, research centres, and ministries to test-bed and adopt their tubular solar PV technology. The technology owner is also seeking industrial partners (e.g., manufacturers, system integrators, architects, designers, etc) to co-develop a complete solar energy solution or integrate the tubular solar PV modules into specific use cases. The technology owner has developed an innovative tubular solar PV module that integrates flexible thin-film solar PV stripes into glass tubes arranged in parallel. The unique design allows for the permeation of sunlight, rain, and wind through the module. The key features of this technology are: Efficient sunlight utilisation: unique design allows it to capture more direct sunlight for electricity conversion Sunlight and rainwater permeability: increase productivity and crop yields Wind permeability: enable the usage of structures with lower load bearing, reducing the system cost Partial cooling shading: reduce moisture loss and protects the plants from excessive solar radiation Consistent protection: protect the plants below from heavy rain and hail damage Long-term reliability: monolithic PV cells continue work when partially damaged or shaded Self-cleaning capability due to cylindrical shape: reduce maintenance cost compared to conventional panels Modular design with various sizes: allow customisation for specific requirements and facility scalability Horizontal solar PV elevation: enable simple and fast installation (seamless array over large area) The potential applications include but are not limited to: Farms (agriculture, aquaculture, viticulture, horticulture, etc.) Gardens (open gardens, green roofs, etc.) Building façade and rooftop Greenhouses Natural parks, reservoirs, and lakes Other applications (EV charging stations, outdoor canopies, cabanas, pergolas, etc.) The patented technology offers the following unique features: Maximised land-use efficiency: dual use of the land High energy efficiency: constant direct sun exposure Optimised plant growth: light, water, and wind permeability High reliability and good long-term performance Low operating expense (OPEX): negligible maintenance Agrivoltaic Farming, Agrophotovoltaics, Agrisolar, Dual-Use Solar, Ultra Low Light Sensitive PV, Agrivoltaics Energy, Solar, Sustainability, Low Carbon Economy

Rising energy consumption and electricity costs pose significant challenges for all businesses, from light commercial to heavy industrial sectors. Moreover, sustainability has become a crucial component of corporate strategies, particularly within the framework of environmental, social, and governance (ESG). Electrical energy optimisation is not just about cost savings, but also an approach towards resource conservation, power stability, equipment protection, as well as sustainable development. The technology owner has developed a transformer-based voltage optimisation system to reduce energy consumption, optimise electrical power supply, extend equipment lifespan, and lower carbon emissions. This patented technology can control the voltage to an acceptable minimum level and keep the current within the optimum range for best efficiency, providing an immediate and practical way for energy savings. The technology owner is keen to collaborate with industrial partners such as building management, property owners, industrial facility management in manufacturing sectors, etc. The technology owner is also seeking OEM partners to integrate this technology into building management systems (BMS) or co-develop a complete energy saving solution. The core of this technology has the electronic controller regulating the direction of the current in the coil, balancing the phase voltage, and filtering the harmonics from reactive loads, to sustain the highest performance while minimising power loss. The features of this technology are: 8 – 12% reduction in power consumption and electricity bill Improve the quality of overall electrical power supply Over-voltage protection to prolong equipment lifespan Real-time remote monitoring and analysis by app Compact and modular design (easy installation and fast repair) Compatible for both indoor and outdoor installation Enable scalable and customisable adoption for property portfolios Completely self-sufficient solution with virtually unlimited lifespan The voltage optimisation system is applicable for both commercial and industrial applications, especially industrial sectors with energy intensive equipment like motors and cooling devices. The potential applications include but are not limited to: Commercial buildings (shopping malls, office buildings, markets, restaurants, hotels, etc.) Industrial facilities (factories, warehouses, chemical plants, fabrication plants, etc.) Other infrastructures (airports, hospitals, train stations, sports complexes, institutes, etc.) The patented technology offers the following unique features: 8-12% immediate energy savings High efficiency of 99.7% with low system losses Reduce maintenance cost by increasing equipment lifespan Remote monitoring for smart energy management Return on Investment (ROI) in 12-24 months Voltage Optimisation, Energy Saving, Cost Reduction Energy, Sensor, Network, Power Conversion, Power Quality & Energy Management, Electronics, Power Management, Sustainability, Low Carbon Economy

There is an increasing requirement for systems that can detect people in built up space. The requirements come from diverse fields such as safety, security and sustainability. In the field of safety, video cameras or wearables have conventionally been used and both come with significant downsides. Video cameras are highly dependent on the line of sight and are privacy invasive while wearables introduce a burden on the end user. Microwave radar-based solutions are a field of research which can overcome the downsides by being accurate, not burdening the end user and by removing the requirement of line-of-sight. The company provides algorithmic solution in this space based on microwave radar in a Multi Input Multi Output (MIMO) configuration. The solution utilizes biological activity including respiration and heartbeat and consequently does not require measurement of the static environment in advance. The technology consists of an algorithmic solution to allow detection of live bodies using microwave radar. The proof of concept was done using wireless routers with custom antennas. The solution provides a resolution of under 1m for localization. The solution is not dependent on ‘line of sight’. The solution does not require any additional setup process for measurement of static environment and only a simple installation step needs to be performed. Human position is detected based on ‘Angle of Arrival’ calculations. The solution allows shared use of Wi-Fi hardware making it cost competitive versus millimeter wave based solutions. The applications include but are not limited to: Child Safety Monitoring Presence Detection Living Body Localization Security and Intrusion Detection The technology offers a non-invasive and a convenient method of tracking live bodies in a built-up environment. The competing technologies in the space are either inconvenient requiring the person to carry an instrument on them or are invasive because of the use of video cameras. Other non-invasive solutions such as those based on infrared suffer from performance issues as they are adversely affected by environmental factors while the ones using radar and AI require a setup step to recognize the static environment. AI based solutions also lack the capability of localization. An additional advantage of the technology is that it uses standard Wi-Fi allowing routers to compliment or replace additional sensor installation requirements in some cases. Electronics, Sensors & Instrumentation, Radio Frequency, Healthcare, Medical Devices, Infocomm, Internet of Things, Wireless Technology

Blowflies are insects often used for scientific research in fields such as forensics, veterinary science, ecology, and biology. Scientists study them at different stages of their lives, including maggots and adult blowflies.This technology relates to a fully operational and scalable multi-species insectary (Arthropod Containment Level 2) which focuses on harnessing the potential of non-medical blowflies for agricultural and waste management sectors. Firstly, blowfly maggots can be produced at scale to act as biodigesters to break down and convert agri-food waste or side streams to valuable blowfly insect protein. With additional processing, bioactive compounds can be extracted from these insect proteins with diverse applications in medicine and industry. When maggots mature into blowflies, they can be deployed for all-year-round insect pollination instead of bees. This can be conducted in controlled environments, including Indoor Vertical Farms, Greenhouses, and Polytunnels. This application has been validated with state-of-the-art UV lighting technology where blowflies are adept at locating flowers and conducting crucial pollination activities. The technology provider is actively seeking collaborative partnerships with stakeholders from the agriculture sector to enhance crop yields for farmers, while also aiming to collaborate with the waste management industry in order to minimize waste generation and transform it into valuable products through recycling. The insectary is designed with modularity and scalability, allowing for easy expansion or modification of the facility to accommodate various insect populations. It provides a fully contained environment that caters to all stages of the blowfly's life cycle, as well as other insects, ensuring proper housing and management. The insectary maintains a highly controlled environment that complies with Arthropod Containment Level 2 standards, operating as a no-odor facility with negative pressure, approved by National Environment Agency (Singapore). To optimize space utilization within the insectary and maintain separation between different insect populations, insects are carefully housed within netted cages stacked vertically. A specialized diet consisting of homogenized, strictly heterogeneous protein waste is provided to convert waste into valuable insect protein for diverse purposes. The insectary produces a substantial quantity of eggs necessary to sustain a closed-loop protein biodigester system, ensuring a continuous supply of insects for the biodigester. The insectary facilitates the emergence of newly developed blowflies, which can serve as alternative pollinators in Controlled Environment Agriculture (CEA), diversifying and enhancing pollination strategies for improved agricultural productivity. When complemented with a patented UV lighting technology, the insectary creates optimal environmental conditions for flower pollination, stimulating blowflies' active participation in the pollination process. Biodigesters: Blowfly maggots play a crucial role as biodigesters, efficiently converting waste protein into valuable insect protein. This sustainable process not only effectively manages waste but also yields a valuable protein source with diverse applications. Insect Pollinators: Blowflies can serve as effective insect pollinators, detecting flowers that are ready for pollination and being selectively recaptured and removed from indoor farming arenas after completing the pollination process. This innovative approach offers an alternative method of pollination, ensuring optimal crop production and enhancing agricultural sustainability. By harnessing the potential of blowfly maggots in these areas, there is an opportunity to explore innovative and sustainable solutions for both pollination and waste management. This exploration can lead to significant improvements in agricultural practices and resource utilization, contributing to enhanced sustainability in the agricultural sector. This technology also aims to revolutionize the aquaculture industry by eliminating disposables cost associated with waste management in a cost-effective and environmentally friendly manner. Waste Management Capability: The blowfly system is adept at handling high-protein waste, including offal and by-products generated from animal processing facilities like aquaculture. Unlike black soldier flies, blowflies excel specifically in breaking down protein waste. Their effectiveness in degrading protein-rich by-products makes them highly valuable for waste management in industries dealing with such materials. Continuous Supply and Expansion: The continuous supply of blowfly eggs ensures the expansion of current capabilities and guarantees long-term sustainability in waste management practices. This steady availability enables efficient and scalable operations. Ecological Compatibility: The insectary is designed to utilize native blowfly species in any country where it is established, ensuring ecological compatibility. By using local blowfly species, the system maintains harmony with the local ecosystem, promoting biodiversity and ecological balance. Versatile Applications of Insect Protein: Insect protein derived from blowflies serves as a sustainable source of fertilizers and can be further processed to extract bioactive compounds and enzymes. These valuable components meet the demands of medicinal and industrial sectors, expanding the potential uses and commercial value of insect protein beyond waste management. Year-round Pollination: Introducing blowflies as alternative pollinators enables year-round pollination activities, supporting agricultural production regardless of seasonal limitations. This consistent pollination fosters continuous crop growth and yield, contributing to agricultural sustainability. Enhanced Crop Quality and Value: Blowflies, as pollinators, contribute to the generation of better-quality crops, particularly fruiting crops, which command higher value in the market. This enhances the profitability of agricultural producers while meeting the growing demands for high-quality produce, resulting in improved economic outcomes for farmers.         Insectary, Pollination, Waste Valorisation, Agriculture, Biodigestor Life Sciences, Agriculture & Aquaculture, Waste Management & Recycling, Food & Agriculture Waste Management, Sustainability, Circular Economy

With an ageing population and increased prevalence in diabetic onset, predisposition to chronic wounds including bed sores and diabetic foot ulcers poses a challenging situation for severe wound care management. Maggot Debridement Therapy (MDT), the oldest form of medicine has now re-emerged to be a promising treatment modality for chronic wounds. A biological tool, MDT serves as an alternative to surgical debridement. This involves the clinical use of sterile blowfly maggots to remove devitalized or necrotic tissues and reduce pathogen load. Topically applied to the chronic wound bed, this dressing facilitates better absorption, thereby providing an edge over existing interventions that lead to eventual amputations. Available in 2 forms, caged and uncaged, this live biodressing utilises natural biochemical processes of the blowfly larvae to conduct debridement that is comparable or better than conventional techniques in reducing critical wound healing time window. Uniquely designed to be used in both inpatient and outpatient settings, the biodressing enable surgical level debridement bedside, revolutionizing wound care with their precision and versatility. The technology provided include specifications on the operation of an ISO13485 laboratory, the Standard Operating Procedure (SOP) required for clinical usage of MDT as well as provision of training to the local clinicians on the use of MDT. The technology provider is looking to work with medical companies as well as government/medical institutions that are looking to have their patients under MDT to improve surgical outcomes, reduce the strain on the healthcare team and minimize costs associated with chronic wound care. Provision of SOP, Risk Assessment of an ISO13485 certified laboratory and insectary for the development of biodressing as a medical device globally.  Required documentation for local country registration, as per medical regulations. Provision of training for staff on the management of laboratory and insectary as per international standards (ISO13485). Comprehensive clinical documentation consisting of the placement, management, usage, and disposal of maggots. Techniques on the identification of local blowfly species, collection from habitat and method of laboratory sterilisation provided. Provision of essential QA techniques for the verification of biodressing to be safe and pathogen-free during both manufacture and transportation. Providing training to clinicians on the appropriate use and management of the biodressing. Clinical data obtained from the implementation of MDT shows promising patient outcomes and acceptance amongst the following: Patients deemed too high risk of surgery (i.e., poor blood supply) Diabetic patients with chronic wounds Non-healing wounds (i.e., ulcer injuries) Patients contraindicated for antibiotics With MDT, we are able to drive down amputation rates and clinically acquired infections to prepare the wound bed for accelerated healing and reduce time spent at the hospital. According to MarketsandMarkets, the global diabetes care devices market is poised to reach $4.3 Billion by 2025, growing at a CAGR of 16.2% from 2020 to 2025. With MDT, research studies have shown a threefold decrease in amputation rates. The effectiveness of MDT is evident through local clinical data that has demonstrated a limb salvage rate of 90.9% and a wound closure rate of 45.5% in a challenging patient population. With timely medical assistance rendered, risk of amputations is reduced, leading to a higher life expectancy and the element of quality being restored in their lives with confidence and independence.    Maggots exhibits accuracy and precision in the preparation of chronic wound beds, where it indiscriminately feeds on the necrotic tissues while leaving the healthy intact. Clinical studies on maggot therapy have shown that wounds are cleaned up to 18 times faster when compared to conventional methods that has increased rates of human error. Available in 2 forms: Free Range Larvae and Baggots (Maggots are enclosed within a sterile pouch with pores in the dressing to provide direct contact between larvae and wound bed).  Secretions from maggots have been reported to help reduce chronic inflammation and speed up the healing process. Cycling between MDT and Negative Pressure Wound Therapy (NPWT), the rate of wound healing is optimised, while reducing inflammatory exudate and promoting tissue granulation. MDT has been proven beneficial for high-risk patients with chronic wounds that does not respond well to surgical/conventional modes of wound debridement. This is backed up by statistics that shows a successful debridement after 4 weeks of MDT while necrotic tissues were observed even after 5 weeks of conventional therapies. Able to reach areas that are a challenge to access mechanically. Can be administered on patients outside the confinements of a healthcare facility. Maggot Debridement Therapy, Chronic wounds, Sterile medical-grade maggots, Efficacy, Cost Healthcare, Diagnostics, Medical Devices, Pharmaceuticals & Therapeutics

Lignocellulosic biomass side streams derived from the agri-food value chain such as agricultural residues, have the potential to be converted into high-value products, including biofuel, bio-composite construction materials, and sustainable packaging. Among the various conversion processes, pre-treatment plays a crucial role in maximizing the value of lignocellulosic biomass. The primary objective of pre-treatment is to address the complex and heterogeneous structure of the biomass by removing lignin, reducing biomass size, and increasing the surface area for hydrolysis. Unfortunately, current pre-treatment methods for lignocellulosic biomass are energy-intensive, costly, and produce inhibitory compounds that impact subsequent production stages. To overcome these challenges, this technology offers a catalytic oxidation pre-treatment process. This innovative approach operates under ambient or mild conditions, with a short reaction time, resulting in reduced energy consumption and treatment costs. The technology provider is seeking interested parties from the agricultural, biofuels, or biogas industry to license this catalytic oxidation pre-treatment process to enhance their operations and achieve a more sustainable and cost-effective production of valuable products from lignocellulosic biomass. The pre-treatment technology incorporates alkaline solutions, oxidizing agents, and synthetic catalysts to break down the recalcitrant structure of biomass and release soluble lignin. Mild operating conditions @ 1 atm pressure and 40-50oC Requires lower concentration & smaller volume of chemicals @ < 1% (w/v) Short reaction time (2-3 hours) Inhibitory compounds such as furfural and 5-HMF (Hydroxymethylfurfural) are removed in the process through oxidation This technology is mainly applied to pre-treat residual biomass but can be extended to the following applications: Lignin extraction Municipal sludge Palm Oil Mill Effluent (POME) treatment Recalcitrant wastewater treatment The biofuel industry is expected to grow at a CAGR of 7.9% by 2033. As companies look for more sustainable fuels for vehicles that cannot be easily electrised, biofuels will be the most suitable alternative to fossil fuels to cut down on carbon emissions. Valorization of agricultural waste that is rich in lignocellulosic cells as second-generation biofuels is also gaining prominence. Hence, this pre-treatment technology will be highly relevant in the coming years. Up to 90% energy savings @ ambient working conditions No inhibitory products produced High selectivity on aromatic compounds such as lignin increases the delignification effectiveness Lignocellulose, biomass, agrifood, Residual biomass pre-treatment, agriculture waste valorization, side stream Waste Management & Recycling, Waste-to-Energy, Food & Agriculture Waste Management, Sustainability, Circular Economy

With a projected market size of close to US$300M in 2025, printed thin film batteries are emerging as ideal candidates to power the next-generation wearables, medical and electronic devices. Unlike conventional batteries, printed thin-film batteries offers form-factor freedom, flexibility, providing power at sub-milimeter thickness and potentially cost effective to manufacture. Typically, zinc-manganese has been the chemistry of choice for printed batteries thanks to its low cost, high safety and ease of processing. Printed battery is manufactured by depositing conductive ink as a thin-film of paste onto a flexible polymer substrate (e.g., PET or heat-resistant polyimide films) by screen printing technique. Developed by an SME, the proprietary printed battery technology consists of layers of zinc anode, manganese dioxide cathode, electrolyte, separator, current collectors and sealing materials. The final battery is about 0.7 mm thick. While the energy capacities and size/shape could be customised depending on the use cases, the printed battery is best suited for applications at a power consumption of less than 50 mW. The technology owner may provide an initial assessment of the feasibility in using printed battery as a power source. If feasible, the technology owner may support in further brainstorming to optimise the power requirement and battery capacity for potential use cases. With a full grasp of the technical requirements, co-development activities including prototyping, battery integration with the final product (where applicable) will follow. For selected final products, the technology owner may serve as the original equipment manufacturer or original design manufacturer for the technology seeker. The standard non-rechargeable printed battery developed by the technology owner has the following technical specifications: Nominal voltage: 1.5 V to 3.0 V Initial capacities: 15 mAh @ 1 mA to 60 mAh @ 1 mA Initial internal resistance: ~20 Ω to ~90 Ω Maximum peak current: 25 mA for 5 ms Shelf life: minimum 2 years The outer dimensions, thickness and shape of battery as well as terminal size and location can be tailored according to the use cases: Customisation (area): 2 to 100 cm2 Customisation (capacity): up to 400 mAh Bending radius: the printed battery can be attached to a curved surface with a minimum radius of 35 mm. The thin film paper battery may be designed and customised to supply power to the following products and applications: Wireless sensor labels for temperature monitoring or asset tracking Wireless skin patches for monitoring vital signs Cosmetics patches and masks for skin care Smart wound healing dressings Intelligent packaging lighting, display and tracking New products that benefit from the thin and flexible form factor US$296M in 2025 and CAGR 24.7% from 2020-2025 (MarketsandMarkets, 2020) Customisable, flexible printed batteries for multiple applications. Printed battery, Flexible battery, Flexible electronics Energy, Battery & SuperCapacitor

Traditional methods of culturing organoids are labor-intensive, time-consuming, and limited in their ability to produce large quantities of organoids with consistent quality and characteristics. This technology enables the production of homogenized organoids of consistent quality. It utilizes specialized conditions to facilitate mass production and automate the cultivation of organoids derived from various tissues and organs, including the liver, kidney, lung, and brain. The IP addresses a need in the marketplace by providing a more efficient and cost-effective method of producing organoids. This technology reduces the time and cost of producing organoids while improving the reproducibility and scalability of the process. This can accelerate drug discovery and development, improve the accuracy of toxicology testing, enable the development of personalized medicine, and eventually replace the need for animal testing in the long-term vision of drug development. The technology provider will be producing the desired organoids as the end product with a further aim to enable a platform service for toxicity and efficacy testing when fully commercialized. The identity of the organoids will be validated by expression of relevant biomarkers. The end users of this technology are likely to be pharmaceutical companies, biotech firms, academic research institutions, and clinical laboratories. Overall, the technology has the potential to transform the way organoids are produced and used in the biomedical field. The technology owner is actively seeking for R&D collaboration to allow integration into existing protocols and testing with institutions, biotech companies and Contract Research Organizations (CROs). A bioink composition for organoids generation and characterisation Method for creating consistent cell droplets, culturing them in suspension, and sorting them by desired characteristics Cost-effective, leading to a 10x reduction in price Cryopreservation of organoids can be implemented for long-term storage and to ensure stable delivery This solution is intended to be a platform technology to be deployed in the biomedical industry, specifically in drug discovery on molecular drugs or gene therapies, toxicology testing, disease modeling, and personalized medicine, as well as CROs providing testing services and biotech firms developing early-stage drugs. The products that can be marketed based on this technology are organoid assays derived from various human tissues and organs, such as liver, kidney, lung, and brain. These organoids can be used for various applications, including: Testing drug toxicity and efficacy Investigating disease mechanisms and identifying drug targets Developing personalized therapies for patients The organoids market is projected to grow at a significant rate in the coming years, with an increasing demand for personalized medicine and improved drug discovery and toxicology testing methods. According to a report by MarketsandMarkets, the organoids market is expected to reach USD 1,642 million by 2025, growing at a CAGR of 20.4% from 2020 to 2025. The drug discovery outsourcing market was valued at USD 4.03 billion in 2020 and is also expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2021 to 2028, according to a report by Grand View Research. The increasing demand for novel and effective drugs, the rising cost of in-house drug development, and the need to expedite drug development timelines are some of the key factors driving the growth of this market. Pharmaceutical and biotech companies, as well as academic research institutions, are among the key buyers of drug discovery outsourcing services. These companies outsource drug discovery services to Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) to reduce costs and accelerate drug development timelines. The technology represents a significant improvement over the current state-of-the-art in organoid production. Currently, the most common methods for organoid production involve manual culturing, which is prone to variability and can be time-consuming and labor-intensive. Although some automation, such as the use of microfluidics and robotics, has been incorporated into organoid production, these methods are still limited in terms of organoid yield and quality. Our technology offers several advantages and differentiates itself from competitors in several ways: Scalability: One of the key advantages of this technology is its ability to scale up organoid production to an industrial level. The homogenization and suspension of organoids allow for efficient automation and mass production of organoids, reducing the time and cost of production. Standardization: The technology offers a more standardized and reproducible process for organoid production, reducing variability between batches and improving the accuracy of drug testing and development. Versatility: The technology can be applied to generate organoids from various organs and tissues, allowing researchers to study multiple disease models in a more comprehensive manner. This versatility allows for a wider range of applications and increases the potential market size. Cost-effectiveness: The streamlined process and scalability of the technology can lead to significant cost savings compared to other organoid production methods, making it more accessible to researchers and companies. Homogenized organoids, mass production, automation, drug discovery, toxicology testing, personalized medicine, reproducibility, scalability, transformative technology Healthcare, Pharmaceuticals & Therapeutics, Manufacturing, Additive Manufacturing, Life Sciences, Industrial Biotech Methods & Processes

Diabetes is a prevalent and growing health problem worldwide, affecting 1 in 10 people, with 90% of cases being type 2 diabetes. Congenital diabetes also affects 1 in 6 live births. In the next 20 years, diabetes is projected to increase by 46%. More than half a billion people are affected globally, 400,000 of them are in Singapore and if nothing is done by 2050, there will be one million diabetics patients in Singapore.   The company offers two technical solutions in form of a blended powder format: 1) Low Glycaemic Index (GI) and 2) Low Glycaemic Index (GI) with added protein.   The blend is plant-based, a source of protein, high in dietary fibre and replaces sugar from 20% to 100% in recipes across various food and beverage applications, it is versatile, high solubility, no alternation to original taste.   The solution is primarily targeted at Food Service sectors operators and manufacturers who seeks to penetrate the reduced sugar food & beverage market.  The technology consists of a proprietary blend (formulated by a renowned research institute based in Singapore) and consist of ingredients and composition that has clinically proven results of lowered GI. Affordable and cost effective compared to functional sugars No alteration to original taste of recipe Versatility of application due to its high solubility The applications include but are not limited to: Beverage Products (Bubble Tea, Ready-To-Drink, Pre-Packaged, Hot & Cold Beverages) Bakery Products (Cookies, Muffins, Pies, Tarts, Cakes, Brownies) Dairy (Milkshakes, Ice Creams, Gelato, Frozen Yogurt) Desserts (Asian & Western) The global reduced sugar food & beverage market size is at US$46.1bil, growing at CAGR of 9.53% in next 5 years, APAC is the fastest growing region, valued at US$12.9bil. It is a global movement to fight against diabetes through educational campaigns and government intervention. The Singapore Government decided to introduce mandatory nutrition labels and advertising prohibitions for Nutri-Grade beverages across all formats. The innovative solution offers immense versatility, catering to a broad spectrum of food items. Unlike the current state-of-the-art, which primarily focuses on baked goods and rice, the technology is not restricted to the same spectrum offered by competitors. The potential applications of the technology are limitless, offering a significant advantage over existing solutions. Furthermore, clinical trials have been conducted to validate the efficacy of the technology in food product sets them apart from the current state-of-the-art. In addition, the company possess the technological capabilities to demonstrate the effectiveness and efficacy of their solution across a broad range of food items. This ability to provide concrete evidence of their technology's efficacy offers a compelling advantage to customers looking to adopt innovative, effective, and reliable solutions to meet the demands of the growing diabetic and obese market. Low GI, Low Glycaemic Index, Low Glycaemic Load, Diabetics friendly, Low Glycemic Index, Obesity, Reduced sugar, Better for you, Keto friendly, Plant based, vegan, Healthier choice, HCS, Nutri grade, Halal certified Foods, Ingredients